HK1201732A1 - Methods and compositions for treating and diagnosing acute myocardial infarction - Google Patents

Methods and compositions for treating and diagnosing acute myocardial infarction

Info

Publication number
HK1201732A1
HK1201732A1 HK15102292.4A HK15102292A HK1201732A1 HK 1201732 A1 HK1201732 A1 HK 1201732A1 HK 15102292 A HK15102292 A HK 15102292A HK 1201732 A1 HK1201732 A1 HK 1201732A1
Authority
HK
Hong Kong
Prior art keywords
compositions
treating
methods
myocardial infarction
acute myocardial
Prior art date
Application number
HK15102292.4A
Other languages
English (en)
Chinese (zh)
Inventor
Slobodan Vukicevic
Lovorka Grgurevic
Ivo Dumic-Cule
Original Assignee
Genera Istrazivanja D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genera Istrazivanja D O O filed Critical Genera Istrazivanja D O O
Publication of HK1201732A1 publication Critical patent/HK1201732A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
HK15102292.4A 2012-04-25 2015-03-06 Methods and compositions for treating and diagnosing acute myocardial infarction HK1201732A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261638424P 2012-04-25 2012-04-25
US201261638373P 2012-04-25 2012-04-25
PCT/US2013/038294 WO2013163479A1 (en) 2012-04-25 2013-04-25 Methods and compositions for treating and diagnosing acute myocardial infarction

Publications (1)

Publication Number Publication Date
HK1201732A1 true HK1201732A1 (en) 2015-09-11

Family

ID=49483906

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15102292.4A HK1201732A1 (en) 2012-04-25 2015-03-06 Methods and compositions for treating and diagnosing acute myocardial infarction
HK16101638.8A HK1213495A1 (zh) 2012-04-25 2016-02-16 用於治療和診斷急性心肌梗死的方法和組合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16101638.8A HK1213495A1 (zh) 2012-04-25 2016-02-16 用於治療和診斷急性心肌梗死的方法和組合物

Country Status (9)

Country Link
US (1) US20150104455A1 (de)
EP (1) EP2841100A4 (de)
JP (1) JP6133402B2 (de)
CN (1) CN104853773A (de)
AU (1) AU2013251442B2 (de)
CA (1) CA2870365A1 (de)
HK (2) HK1201732A1 (de)
NZ (1) NZ631639A (de)
WO (1) WO2013163479A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015104684A1 (en) 2014-01-10 2015-07-16 Glaxosmithkline Intellectual Property (No.2) Limited Hydroxy formamide derivatives and their use
WO2017006295A1 (en) 2015-07-08 2017-01-12 Glaxosmithkline Intellectual Property (No.2) Limited Hydroxy formamide derivatives and their use
US20180362485A1 (en) 2015-07-09 2018-12-20 Glaxosmithkline Intellectual Property (No. 2) Limited N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORS
MX2023001238A (es) 2020-07-31 2023-03-03 Glaxosmithkline Ip Dev Ltd Proteina de union a antigeno.
CN117074698B (zh) * 2023-10-11 2024-03-15 湖南凯莱谱生物科技有限公司 用于急性心肌梗死早期诊断的标志物组合、试剂盒、系统和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037139A (en) * 1997-06-03 2000-03-14 Wisconsin Alumni Research Foundation System for assaying modulators of procollagen maturation
US20030224501A1 (en) * 2000-03-17 2003-12-04 Young Paul E. Bone morphogenic protein polynucleotides, polypeptides, and antibodies
US20070224201A1 (en) * 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP2518496A3 (de) * 2006-07-21 2013-02-27 GENERA ISTRAZIVANJA d.o.o. BMP-1-Procollagen-C-Proteinase zur Diagnose und Behandlung von Beschädigungen und Erkrankungen an Knochen und Weichgeweben
US8703435B2 (en) * 2007-04-20 2014-04-22 University Of Louisville Research Foundation, Inc. Peptide biomarkers of cardiovascular disease
KR101640381B1 (ko) * 2008-02-22 2016-07-18 에이전시 포 사이언스, 테크놀로지 앤드 리서치 중간엽 줄기세포 입자
JP6029468B2 (ja) * 2009-05-20 2016-11-24 カーディオ３ バイオサイエンシズ エスエイＣａｒｄｉｏ３ Ｂｉｏｓｃｉｅｎｃｅｓ Ｓａ 心臓病治療用医薬組成物

Also Published As

Publication number Publication date
JP6133402B2 (ja) 2017-05-24
US20150104455A1 (en) 2015-04-16
JP2015520736A (ja) 2015-07-23
AU2013251442B2 (en) 2017-07-06
AU2013251442A1 (en) 2014-10-02
NZ631639A (en) 2016-09-30
WO2013163479A1 (en) 2013-10-31
HK1213495A1 (zh) 2016-07-08
EP2841100A4 (de) 2016-03-23
CN104853773A (zh) 2015-08-19
EP2841100A1 (de) 2015-03-04
CA2870365A1 (en) 2013-10-31

Similar Documents

Publication Publication Date Title
HK1214521A1 (zh) 用於治療蛋白質病的組合物和方法
ZA201408580B (en) Detergent composition
EP2922861A4 (de) Biomarkerzusammensetzungen und verfahren
EP2823306A4 (de) Biomarkerzusammensetzungen und verfahren
HK1251796A1 (zh) 治療糖尿病的方法和組合物
EP2875826A4 (de) Zusammensetzung zur vorbeugung oder behandlung von sepsis
PL2662436T3 (pl) Kompozycja detergentu
HK1209633A1 (en) Compositions and methods for treating diabetes
HK1207109A1 (en) Methods and compositions for treating amyloid deposits
EP2834638A4 (de) Verfahren und zusammensetzungen zur diagnose und prognose von sepsis
GB201200707D0 (en) Composition
EP2897630A4 (de) Entzündungshemmende zusammensetzungen zur behandlung von nervenentzündungen
HK1213495A1 (zh) 用於治療和診斷急性心肌梗死的方法和組合物
HK1199198A1 (en) Composition
EP2878295A4 (de) Zusammensetzung
EP2726109A4 (de) Zusammensetzungen und verfahren zur behandlung von skelettmyopathie
EP2931280A4 (de) Verfahren und zusammensetzungen zur hemmung von cnksr1
EP2837670A4 (de) Fluorbiphenylhaltige zusammensetzung
GB201206035D0 (en) Composition
EP2875347A4 (de) Verfahren und zusammensetzungen zur diagnose und prognose von sepsis
EP2910538A4 (de) Zusammensetzung eines gaserzeugungsmittels
EP2910537A4 (de) Zusammensetzung mit einem gaserzeugenden mittel
GB201209597D0 (en) Composition
GB201208133D0 (en) Composition
ZA201500291B (en) Bright detergent composition